newsfilter
← Latest News
Business Wire·

Quanterix Names Dr. Yuri Fesko Chief Medical Officer

  • Quanterix Corporation (NASDAQ: QTRX) appointed Dr. Yuri Fesko as its new Chief Medical Officer.
  • Dr. Fesko will provide medical leadership across Diagnostics, Scientific, R&D, Regulatory, & Commercial teams to advance the company's technologies.
  • His appointment supports the broader market launch of the Lucent AD Complete five biomarker test for Alzheimer's Disease.
  • He will also assist in advancing the IVD filing for the HD-X instrument & building the Diagnostics business.
  • Previously, Dr. Fesko served as Chief Medical Officer at Quest Diagnostics, overseeing Medical Affairs, Clinical Development, Analytics, & Public Health.
  • His career expertise includes precision medicine strategies in oncology, metabolic disease, neurology, & consumer health.
  • Dr. Fesko holds Bachelors & Doctor of Medicine degrees from Case Western Reserve University & is board-certified in Internal Medicine, Hematology, & Medical Oncology.
  • He will be based at Quanterix's Billerica, MA headquarters.